The CEO and CFO selling simultaneously after option exercises is a routine cashless exercise pattern, not a bearish signal. Monitor next 10-Q for any fundamental deterioration, but this cluster alone does not warrant action.
AXSM drugs
AXSM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 11 $253.77entry
- T+1 · 5mo ago +0.55%α +0.01% · $255.17
- T+5 · 5mo ago −0.63%α −1.07% · $252.16
- T+20 · 4mo ago −1.90%α −3.79% · $248.95
- T+60 · 2mo ago −18.56%α −22.95% · $206.68
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Herriot Tabuteau and CFO Nick Pizzie sold a combined ~$19.9M in open-market sales on June 9, 2026, following derivative exercises. Director Mark Coleman also sold $160K. The total open-market sales of ~$20.05M represent ~0.16% of AXSM's $12.6B market cap, a modest but notable cluster. The CEO and CFO selling simultaneously after exercising options is a common liquidity-driven pattern (cashless exercise-to-sell), not a bearish signal.
Key Financial Metrics
Key Facts
- CEO Herriot Tabuteau sold 49,670 shares at $241.01 for ~$11.97M on June 9, 2026
- CFO Nick Pizzie sold 33,000 shares at $240.09 for ~$7.92M on June 9, 2026
- Both CEO and CFO exercised derivatives immediately prior to sales (cashless exercise-to-sell pattern)
- Director Mark Coleman sold 643 shares at $249 for $160K on June 10, 2026
- Total open-market sales: ~$20.05M, representing ~0.16% of AXSM's $12.6B market cap
- No open-market purchases in the cluster; all non-cash transactions (grants, awards, derivative exercises) have $0 economic value
Financial Impact
Total open-market sales of ~$20.05M, ~0.16% of market cap, modest relative to company size
Risk Factors
- Insider sales could signal management's view of near-term headwinds, though the cashless exercise pattern mitigates this
- Further insider selling in coming weeks would increase bearish weight
- Stock is near all-time highs (~$246), profit-taking by insiders is natural
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AXSM-1781142574601 |
Track record
26 reports on AXSM
6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 2, 202614d ago 8-K Bullish 6/10 No price data
- Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
- Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
- Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
- Aug 10, 202614w ago 8-K Neutral 6/10 No price data
- Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
- Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
- Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
- Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
- Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers